Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220020571 220006710 1.55 45 Disease modification (D) 2016-08-12 2017-03-25 Cytarabine Low Dose N null 220025773 CYTARABINE
220020572 220006717 0 81 Curative (C) 2016-11-25 2016-12-27 CYTARABINE 02 N 220025802 CYTARABINE
220020575 220006728 null null Curative (C) 2014-06-27 2014-12-08 AML MyeChild 01 A Mitozantrone/Cytarabine N null 220025841 NOT MATCHED
220020576 220006731 1.55 72 Palliative (P) 2017-07-23 2017-08-02 Cytarabine Low Dose N N 220025844 CYTARABINE
220020577 220021472 null 9.9 Disease modification (D) 2016-06-18 2016-11-18 null N null 220025943 NOT MATCHED
220020578 220022342 null 0 Palliative (P) 2015-10-04 2015-10-05 Hydroxycarbamide N N 220025945 HYDROXYCARBAMIDE
220020579 220006749 null 0 Curative (C) null 2017-12-28 Hydroxycarbamide 2 N 220025947 HYDROXYCARBAMIDE
220020580 220006754 0 35 Curative (C) 2014-05-29 2014-09-18 EZ 02 N 220025965 NOT MATCHED
220020581 220006758 1.78 0 Palliative (P) null 2015-02-12 Hydroxycarbamide N null 220025977 HYDROXYCARBAMIDE
220020582 220013725 0 0 Palliative (P) 2015-06-26 2015-12-14 Hydroxycarbamide N N 220025983 HYDROXYCARBAMIDE
220020583 220006763 null 85.6 Disease modification (D) 2016-07-07 2016-11-21 Hydroxycarbamide N null 220025993 HYDROXYCARBAMIDE
220020584 220006774 null 96.7 null 2013-10-17 2013-10-21 CYTARABINE N null 220026046 CYTARABINE
220020585 220006776 0 12.1 Disease modification (D) 2014-01-08 2014-01-08 null 02 N 220026051 NOT MATCHED
220020587 220013742 1.7 null null 2017-10-25 2017-11-26 Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE null null 220026091 NOT MATCHED
220020588 220013745 1.66 87.2 Palliative (P) 2016-06-13 2016-06-13 Hydroxycarbamide N N 220026122 HYDROXYCARBAMIDE
220020589 220013746 null 85.6 Palliative (P) 2019-03-28 2019-03-29 Hydroxycarbamide N N 220026127 HYDROXYCARBAMIDE
220020590 220006796 null 0 Curative (C) 2017-06-26 2017-06-26 APML Relapse Consolidation N N 220026128 NOT MATCHED
220020591 220006805 0 11.6 Curative (C) 2014-12-31 2015-01-02 AML MyeChild 01 Triple IT 2 N 220026157 NOT MATCHED
220020592 220006813 null 12.1 Curative (C) 2017-01-27 2017-01-31 null N N 220026178 NOT MATCHED
220020593 220017496 1.75 98 Curative (C) 2016-03-07 2016-03-18 ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYCLOPHOSPHAMIDE null N 220026183 NOT MATCHED
220020594 220006819 1.91 null Palliative (P) 2019-06-09 2019-06-09 Hydroxycarbamide N N 220026210 HYDROXYCARBAMIDE
220020595 220006833 1.8 null Curative (C) 2015-11-16 2016-02-11 AML MyeChild 01 FLA N N 220026249 NOT MATCHED
220020596 220006840 1.75 12.4 Curative (C) 2013-10-12 2013-10-19 BMT Fludarabine/Thiotepa/Treosulfan + ATG N N 220026266 NOT MATCHED
220020597 220006845 1.68 null Disease modification (D) 2017-07-30 2017-07-30 null null null 220026282 NOT MATCHED
220020598 220006861 null null Palliative (P) 2018-12-08 2018-12-08 Hydroxycarbamide N N 220026317 HYDROXYCARBAMIDE
220020599 220006867 1.57 13.8 null 2013-04-24 2013-07-07 AML MyeChild 01 B Cytarabine/Daunoxome N N 220026335 NOT MATCHED
220020600 220019598 1.52 73.1 Disease modification (D) 2016-11-26 2016-11-27 AML Relapsed FLA - Idarubicin 02 N 220026341 NOT MATCHED
220020601 220006875 null 63.4 Disease modification (D) 2013-11-28 2013-12-17 Alemtuz+Fludara+Melphalan RIC MUD N N 220026358 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020602 220006878 null 55 Curative (C) 2018-03-09 2018-03-14 Alemtuz+Fludara+Melphalan RIC MUD N N 220026364 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020603 220006881 1.66 0 Curative (C) 2017-09-12 2017-09-13 Dasatinib 2 N 220026371 DASATINIB
220020604 220006887 1.67 null Curative (C) 2019-07-19 2019-07-25 Dasatinib null N 220026391 DASATINIB
220020605 220017513 1.61 70.4 Curative (C) 2017-01-29 2017-01-29 AML 18 TRIAL 01 null 220026415 AML18 TRIAL
220020606 220006892 1.65 86.2 Curative (C) 2015-02-26 2015-03-06 Alemtuz+Fludara+Melphalan RIC MUD N N 220026416 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020607 220006899 1.58 62.4 Curative (C) 2013-05-27 2013-07-25 AML 18 TRIAL N N 220026461 AML18 TRIAL
220020608 220006912 1.7 93.15 Curative (C) 2013-06-30 2013-07-05 Alemtuz+Fludara+Melphalan RIC MUD N N 220026504 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020609 220006919 1.76 84.2 Curative (C) 2016-11-20 2016-11-20 AML18 PILOT TRIAL 1 N 220026565 PILOT TRIAL
220020610 220006924 null 78 Curative (C) 2014-11-27 2014-11-27 Alemtuz+Fludara+Melphalan RIC MUD 2 N 220026577 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020611 220013820 1.6 59 Curative (C) null 2017-09-26 AML 18 TRIAL N null 220026587 AML18 TRIAL
220020612 220006938 null 83.3 Disease modification (D) 2017-11-01 2018-02-05 AML18 PILOT TRIAL N null 220026612 PILOT TRIAL
220020613 220006942 0 64.1 Curative (C) 2016-12-13 2016-12-13 Dasatinib 02 N 220026621 DASATINIB
220020614 220006949 null 58 Palliative (P) 2015-02-02 2015-02-02 AML 18 TRIAL 01 N 220026636 AML18 TRIAL
220020615 220006959 1.81 76.2 Disease modification (D) 2016-09-28 2016-09-29 Rituximab N N 220026681 RITUXIMAB
220020616 220006960 0 101.5 Curative (C) 2013-10-19 2013-11-06 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 2 N 220026683 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020617 220006962 1.6 75.2 Disease modification (D) 2014-10-03 2014-10-03 Rituximab N N 220026693 RITUXIMAB
220020618 220021483 null 127 Curative (C) 2018-10-08 2018-10-08 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 2 N 220026725 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020619 220022261 1.75 0 Not known (9) 2016-03-18 2016-03-18 Dasatinib 02 N 220026734 DASATINIB
220020622 220021484 1.67 92.3 Curative (C) 2016-07-16 2016-07-19 Alemtuz+Fludara+Melphalan RIC MUD 2 null 220026840 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020623 220007009 1.68 71 Curative (C) 2017-11-22 2017-12-24 AML 18 TRIAL N N 220026878 AML18 TRIAL
220020625 220007026 1.73 84 Curative (C) 2017-06-13 2017-06-14 Alemtuz+Fludara+Melphalan RIC MUD 02 N 220026928 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020626 220007035 1.7 null Curative (C) 2018-05-17 2018-05-17 Alemtuz+Fludara+Melphalan RIC MUD null N 220026961 ALEMTUZUMAB + FLUDARABINE + MELPHALAN